case overview: newly diagnosed egfr nsclc
Published 4 years ago • 62 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
3:47
case overview: egfr-positive nsclc
-
3:22
treatment options: newly diagnosed egfr nsclc
-
5:24
case 4: egfr mutation analysis post-osimertinib
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
4:03
approaching a case of egfr non–small cell lung cancer
-
5:00
case 2: testing for egfr in lung adenocarcinoma
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
2:37
a case of egfr-mutant nsclc
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
2:26
egfr mutations in nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
2:02
case overview: unresectable stage 3 nsclc
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
4:59
molecular testing for newly diagnosed nsclc
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
3:55
egfr-mutant nsclc: optimizing therapy selection